490 related articles for article (PubMed ID: 29472855)
1. Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.
Bagheri S; Squitti R; Haertlé T; Siotto M; Saboury AA
Front Aging Neurosci; 2017; 9():446. PubMed ID: 29472855
[TBL] [Abstract][Full Text] [Related]
2. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.
Miller LM; Wang Q; Telivala TP; Smith RJ; Lanzirotti A; Miklossy J
J Struct Biol; 2006 Jul; 155(1):30-7. PubMed ID: 16325427
[TBL] [Abstract][Full Text] [Related]
3. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
Ejaz HW; Wang W; Lang M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
[TBL] [Abstract][Full Text] [Related]
4. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
5. Virtual histology of Alzheimer's disease: Biometal entrapment within amyloid-β plaques allows for detection via X-ray phase-contrast imaging.
Chourrout M; Sandt C; Weitkamp T; Dučić T; Meyronet D; Baron T; Klohs J; Rama N; Boutin H; Singh S; Olivier C; Wiart M; Brun E; Bohic S; Chauveau F
Acta Biomater; 2023 Oct; 170():260-272. PubMed ID: 37574159
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
7. Imbalances in Copper or Zinc Concentrations Trigger Further Trace Metal Dyshomeostasis in Amyloid-Beta Producing
Metaxas A
Front Neurosci; 2021; 15():755475. PubMed ID: 34707479
[TBL] [Abstract][Full Text] [Related]
8. Trace element alterations in Alzheimer's disease: A review.
Cilliers K
Clin Anat; 2021 Jul; 34(5):766-773. PubMed ID: 33580904
[TBL] [Abstract][Full Text] [Related]
9. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
10. Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.
Wong BX; Hung YH; Bush AI; Duce JA
Front Aging Neurosci; 2014; 6():91. PubMed ID: 24860500
[TBL] [Abstract][Full Text] [Related]
11. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease.
Leskovjan AC; Lanzirotti A; Miller LM
Neuroimage; 2009 Oct; 47(4):1215-20. PubMed ID: 19481608
[TBL] [Abstract][Full Text] [Related]
12. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
14. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
[TBL] [Abstract][Full Text] [Related]
15. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
[TBL] [Abstract][Full Text] [Related]
16. The effect of metals on spatial memory in a transgenic mouse model of Alzheimer's disease.
Railey AM; Groeber CM; Flinn JM
J Alzheimers Dis; 2011; 24(2):375-81. PubMed ID: 21239856
[TBL] [Abstract][Full Text] [Related]
17. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
18. Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer's disease and protection effects of zinc and fluvastatin.
Yao D; Jing T; Niu L; Huang X; Wang Y; Deng X; Wang M
Brain Res Bull; 2018 Oct; 143():1-8. PubMed ID: 30227236
[TBL] [Abstract][Full Text] [Related]
19. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
